Gene Signatures and Cancer-Immune Phenotypes Based on m6A Regulators in Breast Cancer
The N6-methyladenosine (m6A) has been considered as a new layer of epitranscriptomic regulation on mRNA processing, stability, and translation. However, potential roles of m6A RNA methylation modification in tumor immune microenvironment (TIME) of breast cancer are yet fully understood. In this stud...
Guardado en:
Autores principales: | Guanghui Zhao, Junhua An, Qian Pu, Wenwen Geng, Haiyun Song, Qianqian Zhao, Haidong Gao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f76e17925c14411190d8771200e8a873 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA
por: Qingli Quan, et al.
Publicado: (2021) -
5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Jiao Hu, et al.
Publicado: (2021) -
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
por: Jiannan Yao, et al.
Publicado: (2021) -
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
por: Gangga Anuraga, et al.
Publicado: (2021) -
A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma
por: Chao Yang, et al.
Publicado: (2021)